InvestorsHub Logo
Followers 7
Posts 754
Boards Moderated 0
Alias Born 07/26/2010

Re: biovalidator post# 9315

Wednesday, 10/02/2013 7:35:52 PM

Wednesday, October 02, 2013 7:35:52 PM

Post# of 40503
Novartis & Novavax both heavily represented at this up coming RSV conference in Portugal. Novavax currently in a phase2 trial for RSV using a nanoparticle vaccine approach and Novartis in preclinical RSV....

http://www.novavax.com/go.cfm?do=Page.View&pid=13
http://www.novartisvaccines.com/products-diseases/pipeline.shtml
http://www.meetingsmanagement.co.uk/index.php?option=com_content&view=article&id=110&Itemid=226
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INO News